{'output': [['Natus Medical', 'COMP', 'Revenue', 'Q4', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Has', 'Weakness', 'CONCEPT'], ['Weakness', 'CONCEPT', 'Located_In', 'U.S.', 'GPE'], ['U.S.', 'GPE', 'Participates_In', 'Neurodiagnostic Business', 'SECTOR'], ['Natus Medical', 'COMP', 'Does_Not_Include', 'Expenses', 'CONCEPT'], ['Expenses', 'CONCEPT', 'Relate_To', 'U.S. Medical Device Tax', 'ORG/REG'], ['Natus Medical', 'COMP', 'Due_To', 'Disruption', 'CONCEPT'], ['Disruption', 'CONCEPT', 'Relate_To', 'Integration', 'CONCEPT'], ['Integration', 'CONCEPT', 'Of', 'Computer Systems', 'COMP'], ['Q4', 'TIME', 'Revenue', 'Lower_Than_Expected', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Has', 'Annual After Tax Cost', 'ECON_INDICATOR'], ['Annual After Tax Cost', 'ECON_INDICATOR', 'Approximately', '$3.0 Million', 'QUANTITY'], ['Natus Medical', 'COMP', 'Increase', 'Investments', 'CONCEPT'], ['Investments', 'CONCEPT', 'In', 'Key Product Areas', 'SECTOR'], ['Natus Medical', 'COMP', 'Announce', '2018 Annual Financial Guidance', 'CONCEPT'], ['Natus Medical', 'COMP', 'Sees', 'FY 2018 Non-GAAP Earnings Per Share', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Sees', 'Q1 2018 Revenue', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Sees', 'FY 2017 Revenue', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Sees', 'FY 2018 Revenue', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Sees', 'Q1 2018 Non-GAAP Earnings Per Share', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Sees', 'Q4 2017 Revenue', 'ECON_INDICATOR'], ['Natus Medical', 'COMP', 'Expect', 'Otoscan Revenues', 'PRODUCT'], ['Otoscan Revenues', 'PRODUCT', 'Ramp', 'Second Half Of 2018', 'TIME']]}